<!DOCTYPE html><html><head><meta charSet="utf-8" class="next-head"/><title class="next-head">ALiEM Cards</title><meta name="viewport" content="initial-scale=1.0, width=device-width" class="next-head"/><meta charset="utf-8" class="next-head"/><meta http-equiv="x-ua-compatible" content="ie=edge" class="next-head"/><link rel="apple-touch-icon" sizes="180x180" href="/static/Favicons/apple-touch-icon.png" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-32x32.png" sizes="32x32" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-16x16.png" sizes="16x16" class="next-head"/><link rel="mask-icon" href="/static/Favicons/safari-pinned-tab.svg" color="#00b092" class="next-head"/><link rel="shortcut icon" href="/static/Favicons/favicon.ico" class="next-head"/><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans" class="next-head"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js" as="script"/><link rel="preload" href="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" as="script"/><link rel="preload" href="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" as="script"/><link rel="preload" href="/_next/static/chunks/styles.9b76ae77785496d5351a.js" as="script"/><link rel="preload" href="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" as="script"/><link rel="stylesheet" href="/_next/static/css/commons.b3e9c004.chunk.css"/><link rel="stylesheet" href="/_next/static/css/styles.0fc85b66.chunk.css"/></head><body><div id="__next"><div data-reactroot=""><div><div class="header" role="banner"><div class="header__logo"><a href="/"><img src="/static/logo.svg"/></a></div><div class="header__nav-button"><button class="hamburger hamburger__squeeze"><span class="hamburger__box"><span class="hamburger__inner"></span></span></button></div><nav class="header__nav header__nav--closed" role="navigation"><ul><li><a href="/cards/">Cards</a></li><li><a href="/categories/">Categories</a></li><li><a href="/about/">About</a></li></ul></nav></div><div class="search"><div class="search__input" role="search"><input type="text" placeholder="Search" aria-label="Search for cards" value=""/></div></div></div><main class="content container" role="main"><article role="article"><h1>Ketofol</h1><div class="card"><div class="card__meta"><div><strong>Author: </strong>Salim Rezaie, MD</div><div><strong>Updated:</strong> <!-- -->3/20/2013</div></div><div class="card__content"><h1 id="ketamine-and-propofol-ketofol-for-procedural-sedation">Ketamine and Propofol (Ketofol) for Procedural Sedation</h1>
<h2 id="take-home-points">Take Home Points</h2>
<ul>
<li><span class="drug">Ketofol</span> is a combination of <span class="drug">ketamine</span> and <span class="drug">propofol</span>.</li>
<li><span class="drug">Ketamine</span> gives you a dissociative sedative, analgesic, and amnestic effect.</li>
<li><span class="drug">Propofol</span> gives you rapid sedation and antiemetic effects. </li>
<li>Overall, it appears that <span class="drug">ketofol</span> could have a slightly better time to sedation, and length of sedation, but this is not statistically significant based on available evidence. However, it does appear that <span class="drug">ketofol</span> does have a more steady sedation depth not requiring as many subsequent doses.  </li>
<li>More studies needed (it would be great to see a three-armed study comparing <span class="drug">ketofol</span>, <span class="drug">ketamine</span>, and <span class="drug">propofol</span> with appropriate and clinically equivalent dosing for each). </li>
</ul>
<h2 id="ketamine-basics">Ketamine Basics</h2>
<p><img src="https://aliemcards.netlify.com/media/ketofol_image-1.png" alt="Ketamine basics table"></p>
<p><span class="drug">Ketamine</span> is a dissociative anesthetic that is a phencyclidine derivative and provides sedation, analgesia, and amnesia. It works by inhibiting catecholamine uptake, which exerts a sympathomimetic effect.</p>
<p><strong>Typical dose:</strong> 1–2 mg/kg IV or 4–5 mg/kg IM</p>
<ul>
<li>Additional doses may be required at increments of 0.5-1 mg/kg. </li>
</ul>
<p><strong>Major adverse outcomes:</strong> airway obstruction, hypoxia, apnea, and laryngospasm. </p>
<ul>
<li>In a meta-analysis, of 8,282 patients, <a href="http://www.ncbi.nlm.nih.gov/pubmed/19201064">Green et al (2009)</a> stated that the total incidence of these major adverse outcomes was only 3.9%. </li>
<li>Vomiting occurs in about 7–26% of patients.</li>
</ul>
<h3 id="what-about-the-elevated-intraocular-pressure-iop-and-intracranial-pressure-icp-that-we-are-always-hearing-about-">What about the elevated intraocular pressure (IOP) and intracranial pressure (ICP) that we are always hearing about?</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/22169582">Drayna et al (2011)</a> found minimal, transient elevations of IOP that were not clinically meaningful. </p>
<ul>
<li>The largest difference from baseline IOP occurred at 15 minutes with an estimated change of only 1.09 mmHg.</li>
</ul>
<h2 id="propofol-basics">Propofol Basics</h2>
<p><img src="https://aliemcards.netlify.com/media/ketofol_image-2.png" alt="Propofol basics table"></p>
<p><span class="drug">Propofol</span> is a lipophilic, ultra short-acting hypnotic agent, which works by potentiating GABA receptors on the neuronal lipid membranes. It does not provide any analgesia, and therefore should not be used as a sole agent for sedation. Note that one of its advantages is its anti-emetic property with a very low incidence of vomiting.</p>
<p><strong>Typical dosing:</strong> 1-2 mg/kg bolus followed by either a continuous infusion at 0.05-0.1 mg/kg/min or by 0.5 mg/kg boluses every 2–3 minutes. 
The <a href="http://www.ncbi.nlm.nih.gov/pubmed/19201064">Pediatric Sedation Research Consortium looked at 49,836 propofol sedation cases</a> and found no instances of death associated with propofol. </p>
<ul>
<li>CPR was required in 2 cases, aspiration occurred in 4 cases, oxygen desaturation (less than 90% for longer than 30 sec duration) occurred in 716 cases, and central apnea occurred in 143 cases. </li>
</ul>
<h2 id="how-do-you-mix-ketofol-">HOW DO YOU MIX KETOFOL?</h2>
<p>No standard dosing regimen established.</p>
<p>Most studies and authors recommend a <strong>1:1 ratio</strong> to provide ease of administration. The medications can be mixed or given sequentially. </p>
<p><strong><a href="https://www.aliem.com/2013/ketofol-game-changer-procedural-sedation/">Click here for full ALiEM blog post</a></strong></p>
<h2 id="references">References</h2>
<ul>
<li>Drayna PC, Estrada C, Wang W, Saville BR, Arnold DH. Ketamine sedation is not 
associated with clinically meaningful elevation of intraocular pressure. <em>Am J
Emerg Med</em>. 2012 Sep;30(7):1215-8. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/22169582">PubMed</a>]</li>
<li>Cravero JP, Beach ML, Blike GT, Gallagher SM, Hertzog JH; Pediatric Sedation
Research Consortium.. The incidence and nature of adverse events during pediatric
sedation/anesthesia with propofol for procedures outside the operating room: a
report from the Pediatric Sedation Research Consortium. <em>Anesth Analg</em>. 2009
Mar;108(3):795-804.  [<a href="http://www.ncbi.nlm.nih.gov/pubmed/19224786">PubMed</a>]</li>
<li>Alletag MJ, Auerbach MA, Baum CR. Ketamine, propofol, and ketofol use for
pediatric sedation. <em>Pediatr Emerg Care</em>. 2012 Dec;28(12):1391-5; quiz 1396-8. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/23222112">PubMed</a>]</li>
<li>Shah A, Mosdossy G, McLeod S, Lehnhardt K, Peddle M, Rieder M. A blinded,
randomized controlled trial to evaluate ketamine/propofol versus ketamine alone
for procedural sedation in children. <em>Ann Emerg Med</em>. 2011 May;57(5):425-33.e2. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/20947210">PubMed</a>]</li>
<li>Andolfatto G, Abu-Laban RB, Zed PJ, Staniforth SM, Stackhouse S, Moadebi S,
Willman E. Ketamine-propofol combination (ketofol) versus propofol alone for
emergency department procedural sedation and analgesia: a randomized double-blind
trial. <em>Ann Emerg Med</em>. 2012 Jun;59(6):504-12.e1-2. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/22401952">PubMed</a>]</li>
<li>Green SM, Roback MG, Krauss B, Brown L, McGlone RG, Agrawal D, McKee M, Weiss 
M, Pitetti RD, Hostetler MA, Wathen JE, Treston G, Garcia Pena BM, Gerber AC,
Losek JD; Emergency Department Ketamine Meta-Analysis Study Group. Predictors of
airway and respiratory adverse events with ketamine sedation in the emergency
department: an individual-patient data meta-analysis of 8,282 children. <em>Ann Emerg
Med</em>. 2009 Aug;54(2):158-68.e1-4.[<a href="http://www.ncbi.nlm.nih.gov/pubmed/19201064">PubMed</a>]</li>
</ul>
</div></div></article></main><div class="footer" role="contentinfo"><div class="container"><div class="row footer__cc"><div class="footer__cc-image"><a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><img alt="creative-commons" src="/static/by-nc-nd.svg"/></a></div><div class="footer__cc-text">This work is licensed under a<!-- --> <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License</a>.</div></div><div class="row footer__links"><div><a href="/contact/">Contact</a></div><div><a href="/contact/">Get Involved</a></div><div><a href="/about/">About</a></div></div><div class="row row--centered"><div class="container footer__disclaimer">ALiEM Cards content is intended for use by healthcare professionals. Users of this site should exercise their own clinical judgment as to the reliability and accuracy of its information. Non-healthcare-professionals who use this site do so at their own risk. Content on this site should not be construed as medical advice. Users should always confer with medical profoessionals regarding decisions about medications, evaluations and other medical treatments.</div></div></div></div></div></div><script>__NEXT_DATA__ = {"props":{"pageProps":{"card":{"slug":"ketofol","title":"Ketofol","authors":["Salim Rezaie, MD"],"categories":[{"slug":"pharmacology","name":"Pharmacology"}],"created":"2013/03/20","updated":null,"body":"\n# Ketamine and Propofol (Ketofol) for Procedural Sedation\n\n## Take Home Points\n\n- \u003cspan class=\"drug\"\u003eKetofol\u003c/span\u003e is a combination of \u003cspan class=\"drug\"\u003eketamine\u003c/span\u003e and \u003cspan class=\"drug\"\u003epropofol\u003c/span\u003e.\n- \u003cspan class=\"drug\"\u003eKetamine\u003c/span\u003e gives you a dissociative sedative, analgesic, and amnestic effect.\n- \u003cspan class=\"drug\"\u003ePropofol\u003c/span\u003e gives you rapid sedation and antiemetic effects. \n- Overall, it appears that \u003cspan class=\"drug\"\u003eketofol\u003c/span\u003e could have a slightly better time to sedation, and length of sedation, but this is not statistically significant based on available evidence. However, it does appear that \u003cspan class=\"drug\"\u003eketofol\u003c/span\u003e does have a more steady sedation depth not requiring as many subsequent doses.  \n- More studies needed (it would be great to see a three-armed study comparing \u003cspan class=\"drug\"\u003eketofol\u003c/span\u003e, \u003cspan class=\"drug\"\u003eketamine\u003c/span\u003e, and \u003cspan class=\"drug\"\u003epropofol\u003c/span\u003e with appropriate and clinically equivalent dosing for each). \n\n## Ketamine Basics\n\n![Ketamine basics table](https://aliemcards.netlify.com/media/ketofol_image-1.png)\n\n\u003cspan class=\"drug\"\u003eKetamine\u003c/span\u003e is a dissociative anesthetic that is a phencyclidine derivative and provides sedation, analgesia, and amnesia. It works by inhibiting catecholamine uptake, which exerts a sympathomimetic effect.\n\n**Typical dose:** 1–2 mg/kg IV or 4–5 mg/kg IM\n\n- Additional doses may be required at increments of 0.5-1 mg/kg. \n\n**Major adverse outcomes:** airway obstruction, hypoxia, apnea, and laryngospasm. \n\n- In a meta-analysis, of 8,282 patients, [Green et al (2009)](http://www.ncbi.nlm.nih.gov/pubmed/19201064) stated that the total incidence of these major adverse outcomes was only 3.9%. \n- Vomiting occurs in about 7–26% of patients.\n\n### What about the elevated intraocular pressure (IOP) and intracranial pressure (ICP) that we are always hearing about?\n\n[Drayna et al (2011)](http://www.ncbi.nlm.nih.gov/pubmed/22169582) found minimal, transient elevations of IOP that were not clinically meaningful. \n\n- The largest difference from baseline IOP occurred at 15 minutes with an estimated change of only 1.09 mmHg.\n\n## Propofol Basics\n\n![Propofol basics table](https://aliemcards.netlify.com/media/ketofol_image-2.png)\n\n\u003cspan class=\"drug\"\u003ePropofol\u003c/span\u003e is a lipophilic, ultra short-acting hypnotic agent, which works by potentiating GABA receptors on the neuronal lipid membranes. It does not provide any analgesia, and therefore should not be used as a sole agent for sedation. Note that one of its advantages is its anti-emetic property with a very low incidence of vomiting.\n\n**Typical dosing:** 1-2 mg/kg bolus followed by either a continuous infusion at 0.05-0.1 mg/kg/min or by 0.5 mg/kg boluses every 2–3 minutes. \nThe [Pediatric Sedation Research Consortium looked at 49,836 propofol sedation cases](http://www.ncbi.nlm.nih.gov/pubmed/19201064) and found no instances of death associated with propofol. \n\n- CPR was required in 2 cases, aspiration occurred in 4 cases, oxygen desaturation (less than 90% for longer than 30 sec duration) occurred in 716 cases, and central apnea occurred in 143 cases. \n\n## HOW DO YOU MIX KETOFOL?\n\nNo standard dosing regimen established.\n\nMost studies and authors recommend a **1:1 ratio** to provide ease of administration. The medications can be mixed or given sequentially. \n\n**[Click here for full ALiEM blog post](https://www.aliem.com/2013/ketofol-game-changer-procedural-sedation/)**\n\n## References\n\n- Drayna PC, Estrada C, Wang W, Saville BR, Arnold DH. Ketamine sedation is not \nassociated with clinically meaningful elevation of intraocular pressure. _Am J\nEmerg Med_. 2012 Sep;30(7):1215-8. [[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22169582)]\n- Cravero JP, Beach ML, Blike GT, Gallagher SM, Hertzog JH; Pediatric Sedation\nResearch Consortium.. The incidence and nature of adverse events during pediatric\nsedation/anesthesia with propofol for procedures outside the operating room: a\nreport from the Pediatric Sedation Research Consortium. _Anesth Analg_. 2009\nMar;108(3):795-804.  [[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19224786)]\n- Alletag MJ, Auerbach MA, Baum CR. Ketamine, propofol, and ketofol use for\npediatric sedation. _Pediatr Emerg Care_. 2012 Dec;28(12):1391-5; quiz 1396-8. [[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23222112)]\n- Shah A, Mosdossy G, McLeod S, Lehnhardt K, Peddle M, Rieder M. A blinded,\nrandomized controlled trial to evaluate ketamine/propofol versus ketamine alone\nfor procedural sedation in children. _Ann Emerg Med_. 2011 May;57(5):425-33.e2. [[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20947210)]\n- Andolfatto G, Abu-Laban RB, Zed PJ, Staniforth SM, Stackhouse S, Moadebi S,\nWillman E. Ketamine-propofol combination (ketofol) versus propofol alone for\nemergency department procedural sedation and analgesia: a randomized double-blind\ntrial. _Ann Emerg Med_. 2012 Jun;59(6):504-12.e1-2. [[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22401952)]\n- Green SM, Roback MG, Krauss B, Brown L, McGlone RG, Agrawal D, McKee M, Weiss \nM, Pitetti RD, Hostetler MA, Wathen JE, Treston G, Garcia Pena BM, Gerber AC,\nLosek JD; Emergency Department Ketamine Meta-Analysis Study Group. Predictors of\nairway and respiratory adverse events with ketamine sedation in the emergency\ndepartment: an individual-patient data meta-analysis of 8,282 children. _Ann Emerg\nMed_. 2009 Aug;54(2):158-68.e1-4.[[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19201064)]\n"}}},"page":"/card","pathname":"/card","query":{"slug":"ketofol"},"buildId":"1~ee3OFOv6kXxZUoU_eCb","nextExport":true};__NEXT_LOADED_PAGES__=[];__NEXT_REGISTER_PAGE=function(r,f){__NEXT_LOADED_PAGES__.push([r, f])}</script><script async="" id="__NEXT_PAGE__/card" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js"></script><script async="" id="__NEXT_PAGE__/_app" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js"></script><script async="" id="__NEXT_PAGE__/_error" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js"></script><script src="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" async=""></script><script src="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" async=""></script><script src="/_next/static/chunks/styles.9b76ae77785496d5351a.js" async=""></script><script src="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" async=""></script></body></html>